Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2inhibitor
Authors:
- S. YedgarSYS. Yedgar
- L. AptekarLAL. Aptekar
- O. SchwobOSO. Schwob
- G. GoshenGGG. Goshen
- A. GruzmanAGA. Gruzman
- S. SassonSSS. Sasson
- M. LigumskyMLM. Ligumsky
- 1 September 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 285 (3) , G586-G592
Abstract
The pathophysiology of inflammatory bowel disease (IBD) involves the production of diverse lipid mediators, namely eicosanoids, lysophospholipids, and platelet-activating factor, in which phospholipase A2(PLA2) is the key enzyme. Accordingly, it has been postulated that control of lipid mediator production by inhibition of PLA2would be useful for the treatment of IBD. This hypothesis was tested in the present study by examining the therapeutic effect of a novel extracellular PLA2inhibitor (ExPLI), composed of carboxymethylcellulose-linked phosphatidylethanolamine (CMPE), on trinitrobenzenesulfonic acid-induced colitis. Intraperitoneal administration of CMPE suppressed the colitis as measured by mortality rate, intestinal permeability, plasma PLA2activity, intestinal myeloperoxidase activity, and histological morphometry. Current therapeutic approaches for inflammatory conditions focus on the selective control of a lipid mediator(s) (e.g., prostaglandins or leukotrienes). The present study supports the concept that inclusive control of lipid mediator production by PLA2inhibition is a plausible approach to the treatment of colitis and introduces the ExPLIs as a prototype of a novel NSAID for the treatment of intestinal inflammation.Keywords
This publication has 41 references indexed in Scilit:
- Selective COX-2 inhibitors: Are they safe for the stomach?Gastroenterology, 1998
- Phospholipase A2 in inflammatory bowel disease ReplyGut, 1997
- EICOSANOIDS AND INFLAMMATORY BOWEL DISEASEGastroenterology Clinics of North America, 1996
- H2O2 renders cells accessible to lysis by exogenous phospholipase A2: a novel mechanism for cell damage in inflammatory processesFEBS Letters, 1996
- Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2Life Sciences, 1995
- MECHANISM AND PREVENTION OF CHRONIC COLONIC INFLAMMATION WITH TRINITROBENZENE SULFONIC ACID IN RATSClinical and Experimental Pharmacology and Physiology, 1992
- Cytokines and platelet-activating factor in human inflamed colonic mucosaInflammation Research, 1992
- Phospholipase A2 — a mediator between proximal and distal effectors of inflammationImmunology Today, 1991
- In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.Gut, 1987
- Effect of Triton X-100 on the hydrolysis of sphingomyelin by sphingomyelinase of rat brainBiochemistry, 1976